Guest Editorial The ocean in which we floatHarassment in oncology is pervasive—just look at the data June 11, 2021Vol.47 No.23By Stephanie L. Graff, Ishwaria Subbiah, Merry Jennifer Markham, Laurie Beth Matt-Amaral, Julia Lee Close, Kent A. Griffith and Reshma Jagsi
Free Narjust Duma: “To all minority fellows, residents, and medical students—you belong in medicine” June 11, 2021Vol.47 No.23By Alexandria Carolan
RIP MTD: FDA to require sponsors to determine optimal dosage before initiating pivotal trials in cancer June 11, 2021Vol.47 No.23By Paul Goldberg
Guest Editorial Optimize the dose: An optimal step forward for FDA June 11, 2021Vol.47 No.23By Mark J. Ratain, Garth W. Strohbehn, Ian F. Tannock and Allen S. Lichter
FreeIn the Archives Roswell Park, MD Anderson, Memorial Sloan Kettering: The cancer centers that set the model for a nation June 11, 2021Vol.47 No.23
Conversation with The Cancer Letter COTA’s Miruna Sasu: I left pharma to “turn the spigot on” in the real-world data industry June 11, 2021Vol.47 No.23By Matthew Bin Han Ong
Cancer History ProjectFree Dan Hayes witnessed cancer history, now he is documenting it in a podcast June 04, 2021Vol.47 No.22By Alexandria Carolan
Free As Axel Grothey becomes an emblem of sexual misconduct in medicine, many warn that the problem is bigger than one man June 04, 2021Vol.47 No.22By Alexandria Carolan and Paul Goldberg
FreeWhite House Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H June 04, 2021Vol.47 No.22By Matthew Bin Han Ong
FreeIn the Archives Breaking new ground: Nathaniel Berlin, Paul Marks, and Val Skinner June 04, 2021Vol.47 No.22
